Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,140 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

NCT04514029

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

NCT03794635

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, +20 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

NCT05952037

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: City of Hope National Medical Center Duarte, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States

University of Miami Miami, Florida, United States

View all 72 locations

View Trial Details

Active, Not Recruiting

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

NCT06744075

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +14 more
Locations: Hôpital Jacques Monod Montivilliers, France

Centre Henri Becquerel Rouen, France

View Trial Details

Active, Not Recruiting

Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

NCT05019976

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

NCT05410418

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

NCT03330691

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Riley Hospital for Children Indianapolis, Indiana, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

NCT03696784

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +17 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Active, Not Recruiting

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

NCT02932280

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Disease, +18 more
Locations: Phoenix Children'S Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States

Arnold Palmer Hospital for Children Orlando, Florida, United States

View Trial Details

Active, Not Recruiting

A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients

NCT03352765

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions